Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - SHORT-TERM DEBT
Short-term Debt NVAX - Novavax, Inc.
5.14 M
LAST VALUE
-80.15%
2 YEAR CAGR
0.00%
5 YEAR CAGR
17.97%
10 YEAR CAGR